Heart disease manifestations
Pro Research Analysisby 
Searched over 200M research papers
Heart Disease Manifestations: A Comprehensive Overview
Cardiac Manifestations in COVID-19 Patients
Acute Cardiac Injury and Arrhythmias
COVID-19, primarily a respiratory illness, has significant cardiac implications. Acute cardiac injury, marked by elevated cardiac troponins, is a common manifestation, occurring in approximately 8-12% of patients . The frequency of acute cardiac injury in COVID-19 patients ranges from 15% to 33% . Arrhythmias are also prevalent, affecting 3.1% to 6.9% of non-severe cases and 33.0% to 48.0% of severe cases .
Myocarditis and Acute Coronary Syndromes
Myocarditis and acute coronary syndromes are other critical cardiac complications associated with COVID-19. Severe cases report acute coronary syndromes in 6% to 33% of patients . The mechanisms behind these manifestations include direct myocardial injury due to viral involvement and systemic inflammation .
Cardiovascular Disease and Gender Differences
Lifetime Risk and First Manifestation
Men and women exhibit different patterns in the first manifestation of cardiovascular disease. Men are more likely to experience coronary heart disease as their first event, while women are more prone to cerebrovascular disease or heart failure . At age 55, the lifetime risk of cardiovascular disease is similar for both genders, but the type and timing of the first event differ significantly .
Ischemic Heart Disease: Clinical Assessment
Diagnostic Techniques
Ischemic heart disease is assessed using various clinical techniques, including heart rate, blood pressure, electrocardiogram (ECG), symptoms, and changes in heart sounds. These measurements are crucial for accurate diagnosis, prognosis, and management of the disease .
Heart Failure and Chronic Kidney Disease in Type 2 Diabetes
First Manifestation and Mortality Risk
In patients with type 2 diabetes, heart failure (HF) and chronic kidney disease (CKD) are common first manifestations of cardiovascular disease. These conditions significantly increase mortality risk, with hazard ratios of 2.02 for HF and 2.05 for CKD . The combination of HF and CKD presents the highest risk, emphasizing the need for preventive strategies .
Cardiac Manifestations in Autoimmune and Genetic Disorders
Antiphospholipid Syndrome (APS)
APS, an autoimmune disease, often involves the heart through immune-mediated or thrombotic mechanisms. Common cardiac manifestations include valve abnormalities, coronary artery disease, myocardial dysfunction, and pulmonary hypertension. Heart valve lesions, observed in about one-third of primary APS patients, are typically not hemodynamically significant but require close monitoring .
Cardiac Sarcoidosis
Cardiac sarcoidosis, though rare, is life-threatening and presents with heart failure, conduction system disease, and arrhythmias. Diagnosis relies on clinical history and imaging evidence of inflammation and myocardial scarring .
Mitochondrial Disorders
Cardiac involvement in mitochondrial disorders (MIDs) includes cardiomyopathy, arrhythmias, heart failure, and other abnormalities. Hypertrophic cardiomyopathy is the most frequent cardiac manifestation, followed by dilated cardiomyopathy and noncompaction .
Connective Tissue Diseases
Cardiac manifestations are common in connective tissue diseases, with pericarditis being the most frequent. Other manifestations include valvulopathy, coronary artery disease, and conduction disturbances. Regular ECG and echocardiography are recommended for early detection and management .
Muscular Dystrophies
Hereditary muscular dystrophies often lead to cardiac disease, affecting both myocardial cells and the conduction system. This can result in cardiomyopathy, heart failure, and arrhythmias. Early and active investigation is crucial for managing these cardiac complications .
Conclusion
Heart disease manifests in various forms across different conditions, from infections like COVID-19 to chronic diseases such as diabetes and genetic disorders. Understanding these manifestations and their implications is essential for effective diagnosis, management, and treatment. Regular monitoring and preventive strategies are vital in reducing the morbidity and mortality associated with cardiac complications.
Sources and full results
Most relevant research papers on this topic